학술논문

Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study
Document Type
Article
Source
In: Inflammatory Bowel Diseases. (Inflammatory Bowel Diseases, 1 July 2022, 28(7):1034-1044)
Subject
Language
English
ISSN
15364844
10780998